Investigator Details
Taichun Qin
Investigation Details
Last Issued Date
September 26, 2023
No. of 483’s Issued
since 2023
9
Warning Letters Issued
3
Detailed Analysis
Approach:
Taichun Qin closely inspects drug production facilities, paying particular attention to containment and cleaning practices, component quality, laboratory testing protocols, and instrument calibration. He prioritizes thoroughness and compliance with regulatory standards.
Profile:
Taichun Qin is a detail-oriented FDA auditor who focuses on drug production practices, cleanliness, and laboratory testing. He is particularly concerned with preventing cross-contamination, ensuring the use of pharmaceutical-grade components, and maintaining proper testing and calibration procedures.
Top Process Types:
- Sample Testing
- Contamination Control
- Batch Release
- Facility Design
- Environmental Monitoring
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now